PTP | Cloud Experts | Biotech Enablers

Using Document Summarization Successfully in Biotech Research

Mai Hiraoka — Tue, 16 Sep 2025 01:06:39 +0000

Using Document Summarization Successfully in Biotech Research

A biotech company partnered with PTP to deploy an AWS Bedrock-powered summarization system thatreduced document review time by 50% , improved collaboration, and ensured sensitive research data remained secure.

Challenges

Solutions

Results

Conclusion

Overview

As a pioneer in allogenic cell therapies, the Company manages enormous volumes of research documentation. From peer-reviewed publications and preclinical trial data to internal experimental reports, the sheer weight of information often slowed the ability of scientists, clinicians, and executives to extract the insights that mattered most.

The problem was not access — the Company had plenty of data — but speed and clarity. Key findings were often buried in 50-page reports or technical papers that took hours to digest. Scientists were spending precious time parsing documents instead of running experiments. Executives, meanwhile, needed concise and regulator-ready summaries to make informed strategic decisions.

The Company recognized the potential for Generative AI (GenAI) to transform this workflow. However, like many biotech companies working with sensitive data, the Company had strict security requirements that ruled out SaaS-based LLMs. Public AI services carried risks of intellectual property leakage and compliance violations. The Company turned to PTP to design a secure, AWS-native summarization solution that met both technical and regulatory needs.

The Challenge

The barriers the Company faced were familiar across biotech, but particularly acute in high-stakes cell therapy research:

1. Information Overload

Internal teams were consuming dozens of dense scientific papers and clinical trial reports weekly. Extracting actionable findings took too long.

2. Inconsistent Summaries

Human-created summaries varied in quality and clarity. The lack of standardization created friction in cross-functional collaboration.

3. Security Concerns

With sensitive internal research data at stake, SaaS LLMs were not an option. Any solution had to operate within the Company’s secure AWS environment with guardrails for HIPAA and GxP compliance.

The Company wanted a system that could:

Rapidly summarize both internal documents and external publications.
Provide consistent, regulator-friendly outputs.
Operate entirely within a secure, compliant AWS architecture.

The Solution

PTP architected and delivered a secure, GenAI-powered summarization framework running on AWS Bedrock. The solution balanced cutting-edge AI capabilities with the compliance, scalability, and security posture biotech companies demand.

Key Solution Components

AWS Bedrock for Summarization

Bedrock was selected for its flexible access to multiple foundation models through a single API. PTP used prompt engineering and light fine-tuning to optimize summaries for research clarity and regulatory tone.

Amazon S3 as a Secure Document Repository

Internal research documents and curated external publications were ingested into Amazon S3, providing a single, secure repository. This ensured data stayed within the company’s AWS boundary.

Amazon Textract & Kendra for Preprocessing

Amazon Textract converted PDFs and scanned documents into structured text. Amazon Kendra added intelligent search across documents, ensuring the summarization system could pull relevant context before generating outputs.

Custom Prompt Engineering

PTP developed domain-specific prompts that emphasized clarity, neutrality, and regulator-friendly formatting. This ensured that summaries were not only concise but also aligned with FDA communication standards.

Researcher-Facing Chatbot Interface

Instead of adding another dashboard, PTP delivered a simple, secure chatbot UI powered by Open WebUI. Scientists could upload a document, ask for a summary, or request key findings, and receive results in seconds.

Why AWS

The company selected AWS as the backbone for this project because of three critical advantages:

Security and Compliance

With sensitive research data at the core of operations, AWS provided a secure, compliance-ready environment. S3, SageMaker, and Bedrock operated within the company’s isolated VPC, ensuring data never left the secure boundary.

Breadth of Model Choice

AWS Bedrock offered access to multiple foundation models through a unified API, allowing experimentation with ProtGPT2, ProtBERT, and other specialized models without costly redevelopment.

Scalability

AWS’s elastic infrastructure meant the company could scale computationally intensive protein folding workloads up or down as research demands shifted. This flexibility allowed acceleration without overinvesting in static infrastructure.

Why PTP

The company chose PTP as its partner because of its deep expertise in both AWS consulting and life sciences R&D.

Life Sciences Competency

As an AWS Life Sciences Competency partner, PTP brought domain-specific knowledge of biotech workflows, regulatory constraints, and scientific data handling.

Proven AWS Delivery

With years of AWS consulting experience, PTP designed and delivered a pipeline that adhered to AWS best practices while meeting the company’s unique research needs.

Innovation and Enablement

Beyond building the system, PTP enabled the company’s team with training, documentation, and extensibility—ensuring they could independently grow the framework to support future research initiatives.

The Results

The deployment produced immediate benefits:

50% Faster Document Review

Scientists reported cutting review time in half. Instead of spending hours parsing journal articles, they received concise, contextually accurate summaries in minutes.

Improved Cross-Team Collaboration

Standardized summaries meant clinical, research, and executive teams were aligned faster, reducing friction and duplication of effort.

Greater Focus on Research

Scientists spent less time on administrative reading and more time in the lab, directly accelerating experimental throughput.

Secure and Scalable Foundation

By operating fully on AWS, the Company eliminated the risks associated with SaaS GenAI tools and built a foundation it could extend to future research applications.

Conclusion

The Company’s use of AWS Bedrock-powered summarization demonstrates how secure, domain-specific GenAI can solve one of biotech’s most pervasive challenges: turning mountains of research documents into actionable knowledge.

By partnering with PTP, the Company accelerated document review, improved collaboration, and gave scientists more time to innovate—all while keeping sensitive data protected. The project illustrates the power of combining AWS’s secure AI services with PTP’s life sciences expertise to deliver measurable, real-world impact.

Unlock Faster, Smarter Research with AI-Powered Summarization

Accelerate discovery by transforming dense scientific documents into concise, regulator-ready insights. Partner with PTP to deploy secure, AWS-native AI solutions that save time, improve collaboration, and keep sensitive data protected.

Schedule a call

Schedule your free consultation today.

Tell us a bit about your project to get started with PTP. Fill out the form below and our team will be in touch shortly.

The post Using Document Summarization Successfully in Biotech Research appeared first on PTP | Cloud Experts | Biotech Enablers.

Accelerating Clinical Trial Design with AWS Bedrock Agents

Mai Hiraoka — Tue, 16 Sep 2025 00:33:49 +0000

Accelerating Clinical Trial Design with AWS Bedrock Agents

By deploying AWS Bedrock Agents, the company streamlined clinical trial design, cutting protocol drafting from weeks to hours while improving accuracy, consistency, and scalability across its R&D programs.

Challenges

Solutions

Results

Conclusion

Overview

A research-driven biotech is advancing its pipeline through data-intensive drug discovery and clinical development. Among the most resource-heavy steps in this journey is clinical trial design—a process requiring teams to comb through thousands of historical studies, extract eligibility criteria and endpoints, and draft complex protocols that meet regulatory standards.

While critical to bringing new therapies to patients, protocol design is time-consuming, repetitive, and a frequent bottleneck. The Company sought to test whether Generative AI (GenAI) agents built on AWS Bedrock could streamline trial design, accelerate protocol drafting, and improve consistency across its development programs. Partnering with PTP, the Company launched a proof of concept (POC) centered on two Bedrock-powered clinical development agents, laying the foundation for an extensible GenAI framework to support future R&D needs.

The Challenge

Designing and validating clinical trial protocols introduced two major challenges for The Company:

1. Historical Trial Review

Researchers manually searched ClinicalTrials.gov and related datasets to identify prior studies by condition, intervention, and outcome measures. This repetitive task often took hours or days, with results varying by individual researcher skill and experience.

2. Protocol Drafting

Even with access to templates, drafting trial protocols remained slow and labor-intensive. Researchers had to synthesize best practices from multiple studies, structure content into regulator-ready formats, and iterate through multiple internal reviews.

These inefficiencies slowed R&D progress, delayed hypothesis testing, and consumed valuable researcher time. The Company’s goal was clear: use GenAI to automate repetitive tasks, generate consistent protocol drafts, and free its scientists to focus on innovation—all while staying within compliance boundaries by using public, non-sensitive data.

The Use Case: Clinical Development Protocol Design & Trial Planning

The Company evaluated several possible agentic AI applications but chose to focus the POC on clinical development protocol design, recognizing it as one of the highest-impact areas for immediate improvement.

Two AWS Bedrock Agents were deployed:

Clinical Study Search Agent – Retrieves structured data from ClinicalTrials.gov, enabling researchers to explore prior study designs by condition, intervention, or sponsor. It highlights eligibility criteria, endpoints, and outcome measures from past trials.
Clinical Trial Protocol Generator Agent – Builds draft study protocols using best practices and the Common Data Model (CDM), assisting in drafting inclusion/exclusion criteria, endpoints, and statistical plans.

Together, these agents demonstrated how Bedrock could reduce trial design from weeks of manual work to hours, giving The Company a repeatable foundation for scaling future AI-driven research workflows.

The Solution

PTP deployed a modular, AWS-native architecture leveraging Bedrock Agents and supporting services to meet the Company’s requirements.

Key Solution Components

AWS Bedrock Agents for Orchestration

Orchestrated two agents—Study Search and Protocol Generator—designed to work together in surfacing insights and generating structured drafts.

Amazon S3 + Amazon Textract

Public datasets and trial documentation were securely stored in Amazon S3. Amazon Textract converted files into machine-readable formats, ensuring compatibility with Bedrock for indexing and retrieval.

Amazon OpenSearch & Amazon Kendra

Clinical trial datasets were indexed and enhanced with Amazon Kendra for intelligent, natural language search. This allowed researchers to quickly filter and retrieve trial data with higher accuracy than manual searches.

AWS Lambda & Amazon API Gateway

Provided orchestration and secure endpoints, connecting data sources and Bedrock agents into seamless, researcher-facing workflows using AWS Lambda and Amazon API Gateway.

Reference Code Integration

Leveraged AWS’s open-source Bedrock Agents for Healthcare & Life Sciences catalog as a foundation, adapting orchestration chains and prompt templates to the Company’s unique use case.

Demo Interfaces

Delivered a lightweight chat-style interface and Jupyter notebook integration, giving researchers natural, interactive access to the agents and trial drafting workflows.

Why AWS

The company selected AWS as the backbone for this project because of three critical advantages:

Security and Compliance

Breadth of Model Choice

AWS Bedrock offered access to multiple foundation models through a unified API, allowing experimentation with ProtGPT2, ProtBERT, and other specialized models without costly redevelopment.

Scalability

Why PTP

The company chose PTP as its partner because of its deep expertise in both AWS consulting and life sciences R&D.

Life Sciences Competency

As an AWS Life Sciences Competency partner, PTP brought domain-specific knowledge of biotech workflows, regulatory constraints, and scientific data handling.

Proven AWS Delivery

With years of AWS consulting experience, PTP designed and delivered a pipeline that adhered to AWS best practices while meeting the company’s unique research needs.

Innovation and Enablement

The Results

The POC delivered measurable improvements to The Company’s clinical trial design workflows:

Time Efficiency

Trial dataset search times reduced by ~60%, with relevant study details surfaced in seconds.

Accelerated Drafting

Protocol drafts were generated in minutes, saving 2–3 person weeks per protocol.

Improved Consistency

Standardized retrieval and drafting reduced duplication and variability across teams.

Extensibility

Modular design enabled The Company’s team to extend the framework to additional agent use cases beyond the POC.

Conclusion

The Company’s deployment of AWS Bedrock Agents illustrates how Generative AI can revolutionize clinical trial design, one of the most demanding stages in the drug development lifecycle. By automating historical trial search and protocol drafting, the Company accelerated R&D timelines, reduced costs, and freed researchers to focus on higher-value work.

This successful POC establishes a foundation for expanding Bedrock agent use into adjacent areas such as literature reviews, biomarker discovery, and competitive intelligence—further strengthening the Company’s mission to advance life-saving therapies.

Accelerate Your Clinical Development with AI + AWS

See how Generative AI and AWS Bedrock Agents can streamline trial design, reduce costs, and speed innovation. Partner with PTP to bring efficiency and scalability to your R&D programs.

Schedule a call

Schedule your free consultation today.

Fill out the form below and our experts will connect with you to discuss how AI can transform your research.

The post Accelerating Clinical Trial Design with AWS Bedrock Agents appeared first on PTP | Cloud Experts | Biotech Enablers.

Integrating Machine Learning with Generative AI for Protein Research in Life Sciences

Mai Hiraoka — Tue, 16 Sep 2025 00:05:08 +0000

Integrating Machine Learning with Generative AI for Protein Research in Life Sciences

A biotech company partnered with PTP to integrate machine learning and Generative AI on AWS, creating a secure, scalable pipeline that cut research cycle times, improved collaboration, and accelerated therapeutic protein discovery.

Challenges

Solutions

Results

Conclusion

Overview

A clinical-stage biotechnology company, focused on engineering next-generation proteins to accelerate therapeutic innovation, was searching for AI-enabled advancements to their research. At the heart of their pipeline were machine learning (ML) models that predicted protein folding and interaction patterns, helping researchers identify promising therapeutic candidates. While these ML models delivered powerful predictive capabilities, the company’s scientists faced a persistent bottleneck: turning raw predictions into actionable insights.

Protein research is inherently interdisciplinary, requiring collaboration among computational biologists, molecular modelers, chemists, and wet-lab researchers. While ML systems such as AlphaFold could produce detailed folding predictions, these outputs often needed extensive interpretation and translation into experimental briefs. This process consumed valuable time and slowed experimental cycles, hindering the company’s ability to quickly iterate and validate new therapeutic hypotheses.

To address this challenge, the company partnered with PTP to integrate its existing ML pipeline with Generative AI (GenAI) capabilities on AWS Bedrock. The result was a transformative workflow that combined the predictive power of ML with the contextualization strengths of GenAI. Predictions became clear, plain-language, experiment-ready briefs that allowed interdisciplinary teams to collaborate more effectively, shorten research cycles, and accelerate the development of new protein-based therapeutics.

The Challenge

The company’s research bottlenecks were shaped by three interrelated challenges:

Interpretation Gap

The company’s ML models could generate folding predictions and structural interactions, but these outputs were dense, technical, and difficult for non-specialists to interpret quickly. Cross-functional teams had to spend significant time translating computational predictions into insights usable for experimental design.

Time-Consuming Summarization

Reports summarizing ML outputs were drafted manually by data scientists and computational biologists. Each cycle required days of analysis and writing, extending experimental planning cycles and delaying downstream work.

Scaling Research Output

As the company expanded its protein engineering pipeline, the number of candidate proteins under investigation grew dramatically. Scaling human effort to match ML output was not feasible, creating a widening gap between computational predictions and actionable experimentation.

The company set a clear goal: Join ML to GenAI in a seamless pipeline that could automatically generate structured, comprehensible, and actionable reports—without sacrificing scientific rigor or compliance.

The Solution

PTP designed and implemented an integrated ML + GenAI pipeline on AWS that addressed the company’s bottlenecks and established a repeatable research framework.

Key Solution Components

Data Ingestion & Normalization

Raw protein data—including sequences, structural metadata, and prior experimental results—was ingested into Amazon S3 as the central data repository. AWS Glue pipelines performed data cleaning and normalization, ensuring consistent formats across protein datasets. This allowed downstream ML and GenAI systems to interact with structured, reliable inputs.

Protein Folding with AlphaFold

The company’s existing ML capabilities, centered on AlphaFold, were deployed on Amazon SageMaker to predict protein folding and interaction structures. Outputs included 3D models of folded proteins and associated confidence metrics, stored securely in S3 for accessibility. These predictions formed the foundation of the GenAI-driven contextualization step.

Generative AI Summarization with AWS Bedrock

PTP integrated AWS Bedrock into the pipeline, enabling seamless orchestration of large language models (LLMs) specialized for life sciences data. Using ProtGPT2 and ProtBERT as foundational models, the system was fine-tuned on the company’s proprietary dataset of protein predictions and experimental results. Bedrock agents automatically generated plain-language summaries contextualizing folding predictions, highlighting unique structural features, and identifying potential therapeutic implications.

OpenWebUI Research Interface

Instead of relying on pre-packaged SaaS solutions, PTP deployed a custom OpenWebUI front end. Researchers interacted with the pipeline through a simple, intuitive interface:

Submit queries about specific protein candidates.
Retrieve folding predictions and GenAI-generated summaries.
Access structured experiment briefs ready for validation.

Human-in-the-Loop Validation

While GenAI produced clear, structured outputs, the company insisted on maintaining rigorous scientific oversight. Every GenAI-generated report was reviewed by scientists, who could validate, refine, or discard suggestions. Selected protein candidates underwent a secondary lethality re-check, leveraging AlphaFold and additional ML models to ensure safety before moving to wet-lab validation.

Extensible Framework for Future Growth

PTP built the pipeline with modularity in mind. The orchestration layer—anchored on AWS Lambda and Amazon API Gateway—ensured that new GenAI agents or ML models could be added with minimal reconfiguration. Documentation and training were provided so the company’s team could extend the framework independently.

Why AWS

The company selected AWS as the backbone for this project because of three critical advantages:

Security and Compliance

Breadth of Model Choice

AWS Bedrock offered access to multiple foundation models through a unified API, allowing experimentation with ProtGPT2, ProtBERT, and other specialized models without costly redevelopment.

Scalability

Why PTP

The company chose PTP as its partner because of its deep expertise in both AWS consulting and life sciences R&D.

Life Sciences Competency

As an AWS Life Sciences Competency partner, PTP brought domain-specific knowledge of biotech workflows, regulatory constraints, and scientific data handling.

Proven AWS Delivery

With years of AWS consulting experience, PTP designed and delivered a pipeline that adhered to AWS best practices while meeting the company’s unique research needs.

Innovation and Enablement

The Results

The integrated ML + GenAI pipeline delivered measurable impact across The Company’s protein research workflows:

Time Efficiency

Experiment planning cycles shortened by 35%.

Reports that once required days of manual drafting were now generated automatically in minutes.

Research Productivity

Cross-disciplinary teams gained immediate clarity from GenAI-generated summaries, enabling biologists, chemists, and clinicians to collaborate more effectively.

Faster turnaround times allowed the company to expand the number of protein candidates in active development without adding headcount.

Quality and Consistency

Reports generated in plain language improved communication across the organization.

Consistent formatting and structure ensured that every experimental brief was regulator-ready and scientifically coherent.

Scalable Innovation

The modular framework positioned the company to add new GenAI agents for tasks such as literature review, knowledge graph exploration, or biomarker discovery.

The company’s scientists could now focus on higher-value tasks—hypothesis generation, experimental design, and strategic decision-making.

Conclusion

The Company Bio’s integration of ML and GenAI represents a breakthrough in how biotech organizations can accelerate protein research. By pairing AlphaFold-driven predictions with Bedrock-powered contextualization, the Company transformed dense, technical outputs into experiment-ready briefs that fuel collaboration and speed.

The results speak for themselves: shorter research cycles, more scalable experimentation, and higher-quality outputs—all achieved within a secure, AWS-native framework designed for life sciences. With PTP’s expertise, the Company now has a repeatable pipeline that will evolve alongside their research portfolio.

Most importantly, this project underscores how cloud-native AI integration can fundamentally reshape biotech R&D. For the Company, the fusion of ML and GenAI isn’t just an IT upgrade—it’s a strategic capability that empowers scientists to discover, validate, and deliver new protein therapeutics faster than ever before.

Accelerate Your Research with AI + Cloud

Ready to transform complex data into actionable insights? Partner with PTP, an AWS Life Sciences Competency Partner, to harness machine learning and generative AI for faster, more scalable research.

Schedule a call

Schedule your free consultation today.

Tell us a bit about your project to get started with PTP. Fill out the form below and our team will be in touch shortly.

The post Integrating Machine Learning with Generative AI for Protein Research in Life Sciences appeared first on PTP | Cloud Experts | Biotech Enablers.

Streamlining Secure Data Transfers for Financial Applications: Advanced AWS Transfer Family Implementation

Mai Hiraoka — Fri, 04 Jul 2025 03:53:41 +0000

Secure SFTP for Financial Applications in Life Sciences: PTP’s AWS Transfer Family Solution

By deploying AWS Transfer Family with Secrets Manager, Lambda, and enhanced logging, this solution simplified SFTP user management for financial applications, enforced stringent security controls, and enabled seamless compliance auditing.

Challenges

Solutions

Deployment

Conclusion

Executive Summary

PTP is a leading IT services company specializing in managed services and cloud solutions. As a recognized AWS Partner, PTP leverages Amazon Web Services' robust cloud infrastructure to deliver high-performance, scalable, and secure solutions tailored to meet the diverse needs of businesses. PTP provides comprehensive cloud strategies, solutions, and management services that empower businesses to achieve operational excellence.

In this case study, we’ll explore how PTP implemented a secure, automated, and highly available Managed File Transfer (MFT) solution for a customer managing financial data across multiple applications. The customer required stringent security measures, seamless transfer mechanisms, and automated credential management to ensure compliance and minimize IT overhead.

PTP implemented AWS Transfer Family, integrating AWS Secrets Manager for user authentication and credential management with a custom Lambda-based password rotation function. This approach enforced password complexity, rotation compliance, and automation while providing robust endpoint security, granular user access control, encryption, and detailed audit capabilities. By eliminating manual intervention and enhancing compliance, the solution not only addressed security concerns but also simplified access management and offered seamless scalability to adapt to the customer’s growing needs.

Problem Statement

The customer, a life sciences organization operating in a highly regulated GxP environment, required a secure and auditable solution for transferring financial data across multiple vendor applications. Key challenges included:

Compliance: Ensuring adherence to GxP standards for secure file transfers, user authentication processes and auditability.
Security Risks: Preventing unauthorized access to sensitive financial data while implementing robust password and endpoint protection mechanisms.
User Management Complexity: Providing granular access control for multiple named users from different vendors, each requiring isolation and strict permissions.
Operational Overheads: Addressing manual credential rotation and password compliance management that consumed IT resources.
Scalability: Accommodating increasing data volumes and growing user bases with a scalable solution.

These challenges necessitated a secure, automated, and auditable Managed File Transfer (MFT) system designed for high availability and operational efficiency.

Solution Overview

The solution implemented for the Biotherapeutics company included the following key components:

Password Management with AWS Secrets Manager

Passwords for AWS Transfer Family users are stored in AWS Secrets Manager in the format aws/transfer/server-id/username.
A custom Lambda function integrated with API Gateway retrieves these secrets during authentication, ensuring secure, centralized password management.
The Lambda function enforces robust password policies, such as:
- 20-character minimum length with special characters.
- Rotation to prevent reuse of the last 10 passwords.
- Automatic email notifications to users upon password rotation.

Serverless Deployment with AWS SAM CLI

The base of the solution is deployed using AWS Serverless Application Model (SAM) CLI, following Infrastructure-as-Code (IaC) best practices.
Parameters like network configurations, region-specific configurations, and password policies were customized during deployment for optimized integration into the client’s infrastructure.

Custom Authentication via API Gateway and Lambda

AWS Transfer Family relies on a custom authentication provider using API Gateway and Lambda.
Lambda validates user credentials against Secrets Manager and retrieves IAM roles, logical directory mappings, and any IP restrictions.
This design supports dynamic access control and flexible protocol options (SFTP, FTPS, FTP).

CloudWatch Logging and Monitoring

CloudWatch is configured for comprehensive logging and monitoring of the AWS Transfer Family and API Gateway.
Alerts notify the team about suspicious activity or failures, ensuring high availability and security compliance.

Compliance and Security

Source IP address checks are enforced through the custom authentication Lambda.
IAM roles and policies restrict access to only necessary S3 buckets and paths.
All data transfers were encrypted in transit using SFTP protocols, and data at rest in S3 was encrypted with SSE-S3.

Technical Deployment

Password Management with AWS Secrets Manager

Centralized Credential Storage: User credentials are stored in AWS Secrets Manager in the format aws/transfer/server-id/username, ensuring centralized and secure password management.
Custom Password Policies and Rotation: A custom Lambda function is integrated to enforce robust password policies:
- Minimum 20-character passwords with special characters.
- Prevention of reuse of the last 10 passwords.
- Automatic password rotation and notification via email to the respective users.
Automated Rotation: Passwords are rotated periodically using a second Lambda function triggered by Secrets Manager, ensuring compliance with security standards.

Authentication via API Gateway and Lambda

Authentication Flow: AWS Transfer Family relies on a custom authentication provider deployed using API Gateway and a Lambda function.
Dynamic Access Enforcement: During authentication:
- API Gateway triggers Lambda to validate user credentials stored in Secrets Manager.
- Lambda retrieves the associated IAM roles, logical directory mappings, and source IP restrictions dynamically.
Granular Access Control: IAM roles dynamically restrict user access to designated S3 buckets and logical directories, minimizing the risk of unauthorized access.

Serverless Deployment with AWS SAM CLI

The base infrastructure was deployed using AWS Serverless Application Model (SAM) CLI, following Infrastructure-as-Code (IaC) best practices.

Deployment package from AWS blog post was customized to include:

Network configurations (VPC, subnets, security groups).
Region-specific optimizations for the client’s environment.
Additional Lambda function for password rotation and notification.

Monitoring and Logging with CloudWatch

Activity Logging: CloudWatch Logs capture all authentication and data transfer activities across AWS Transfer Family, API Gateway, and Lambda.
Alerting: Custom metrics and alarms are configured to notify the team of suspicious activities or failures.
Audit Reporting: Custom reports are generated using data from Secrets Manager and CloudWatch Logs for auditing purposes.
Insights: These reports track user access patterns, password changes, and failed login attempts.

Compliance and Security Enhancements

End-to-End Encryption: Data in transit is encrypted using SFTP/FTPS, and data at rest in S3 is encrypted using SSE-S3.
Source IP Restriction: Lambda enforces IP address restrictions for enhanced security.
Granular Policies: IAM roles and policies limit users to specific data directories, ensuring they only access their authorized content.

Conclusion

This solution has significantly streamlined the management of approximately 50 external SFTP users in a regulated environment, ensuring robust security controls, seamless automation, and comprehensive logging capabilities. By leveraging AWS Transfer Family with Secrets Manager, Lambda, and supporting services, the solution achieved the following key outcomes:

      Enhanced Security
      Password policies, automated rotation, and prevention of reuse ensure compliance with stringent security standards.
Granular IAM-based access controls restrict users to only their designated data, reducing the risk of unauthorized access.


      Operational Efficiency
      Automation of user credential rotation and direct password delivery minimizes IT team involvement.
Logging and reporting enhancements simplify the monitoring of user activity, making day-to-day management more efficient.


      Streamlined Compliance Audits
      Centralized logging through CloudWatch and custom reports from Secrets Manager provide auditors with clear, actionable insights.
The detailed tracking of user activities and access patterns ensures alignment with regulatory requirements, making audits smoother and faster.

    

This deployment not only meets current operational and security requirements but also positions the system for scalable growth. With automated processes, centralized management, and robust security, the customer is now equipped to handle increasing data transfer demands and evolving compliance needs with confidence.

Simplify credential management and secure data flows with AWS Transfer Family

Learn how PTP helps life sciences teams manage SFTP users, rotate credentials, and stay audit-ready in regulated environments.

Schedule a call

Streamline SFTP Compliance and Credential Automation

Automate secure file transfers, credential rotation, and user access management with AWS Transfer Family—purpose-built for life sciences compliance.

Schedule your free consultation today.

The post Streamlining Secure Data Transfers for Financial Applications: Advanced AWS Transfer Family Implementation appeared first on PTP | Cloud Experts | Biotech Enablers.

Secure & Scalable AWS Transfer Family SFTP Solution for a Therapeutics Company

Mai Hiraoka — Thu, 03 Jul 2025 22:22:18 +0000

Secure & Scalable AWS Transfer Family SFTP Solution for a Therapeutics Company

This document details the deployment of an AWS Transfer Family SFTP solution for a therapeutics company, including setup, user management, and security. It leverages AWS services such as S3, Secrets Manager, API Gateway, and Lambda to enable secure file transfers and user authentication. The solution ensures scalable storage and secure access for external parties.

Challenges

Solutions

Deployment

Conclusion

Executive Summary

PTP is a prominent IT services company and an AWS Partner, known for its expertise in managed services and cloud solutions. They specialize in designing and implementing scalable, secure, and high-performance cloud strategies using Amazon Web Services (AWS). Their services include cloud migration, infrastructure management, and optimization, enabling businesses to enhance operational efficiency and agility.

In this case study, we’ll explore how PTP deployed a secure, scalable, and managed file transfer solution using AWS Transfer Family for a therapeutics company. The solution leverages Amazon S3 for storage, AWS Secrets Manager for secure credential management, Amazon API Gateway for custom authentication, and AWS Lambda for user validation.

This solution enables external parties to securely transfer files to and from the company’s S3 buckets over the public internet using the SFTP protocol. The document provides a detailed guide on the setup, configuration, user management, and security considerations for the SFTP solution, ensuring compliance, scalability, and operational efficiency.

Problem Statement

The therapeutics company implemented a secure and scalable AWS SFTP solution to address key challenges:

Secure File Transfers: AWS Transfer Family ensures encrypted, reliable SFTP transfers over the internet, with S3 providing secure backend storage (SSE-S3).
User Management: Credentials and access control are managed securely via AWS Secrets Manager, with automated validation through API Gateway and Lambda.
Compliance: The solution enforces encryption, IP whitelisting, and least privilege IAM roles, while CloudWatch logging ensures auditability.
Reduced Overheads: Automating user credential management and monitoring minimizes manual intervention.
Scalability: S3's scalability and AWS Transfer Family allow seamless growth in users and data volumes.

This approach delivers a secure, compliant, and efficient SFTP system integrated into the therapeutics company's AWS infrastructure. These challenges necessitated a cloud-based solution that could handle SFTP protocols, manage user credentials securely, and integrate with existing AWS infrastructure.

Solution Overview

The solution implemented for the therapeutics company included the following key components:

AWS Transfer Family

A fully managed service that supports secure file transfers using SFTP, FTPS, and FTP protocols.
Replaces the need for traditional file servers, cutting down on infrastructure management and costs.
Facilitates secure file uploads and downloads directly to/from Amazon S3, making it ideal for external collaboration.

Amazon S3

Offers scalable storage to handle growing file sizes and data volumes effortlessly.
Includes Server-Side Encryption (SSE-S3) to ensure data is encrypted at rest for security.
Versioning feature keeps track of file changes, enabling easy recovery and error management.

AWS Secrets Manager

Provides a centralized, secure repository for storing sensitive credentials like passwords and SSH keys.
Data is encrypted at rest and accessed only through authenticated API calls.
Simplifies credential rotation to meet compliance and security requirements.

Custom Authentication (API Gateway & Lambda)

API Gateway validates user credentials by invoking a Lambda function, which retrieves data from Secrets Manager.
Dynamically assigns IAM roles to limit user access to specific S3 directories based on permissions.
Supports both password and SSH key authentication, with IP whitelisting for added security.

CloudWatch Monitoring

Tracks and logs all authentication and file transfer activities for visibility and compliance purposes.
Monitors key metrics such as login attempts and errors to ensure system availability.
Sends alerts for suspicious activities, enabling quick detection and resolution of potential issues.

Technical Deployment

Password and Credential Management

Secure Storage: User credentials, including passwords and SSH keys, are securely stored in AWS Secrets Manager using a predefined naming format (aws/transfer/server-id/username).
Automated Validation: A Lambda function, integrated with API Gateway, dynamically retrieves and validates credentials during login attempts.
Enhanced Security with IP Whitelisting: The solution includes optional IP whitelisting, restricting access to trusted IP ranges.

Custom Authentication via API Gateway and Lambda

Request Processing: API Gateway passes login credentials to Lambda, which validates them against Secrets Manager.
Dynamic Configuration Enforcement: The Lambda function retrieves:
- IAM Roles: Defines user permissions.
- S3 Access Paths: Limits access to specific folders.
- Logical Directory Mappings: Simplifies SFTP navigation.

Protocol-Specific Support

The architecture supports SFTP, FTPS, and FTP protocols, catering to diverse file transfer requirements.

AWS Transfer Family Setup

Endpoint Configuration: An internet-facing SFTP endpoint is set up with a custom hostname (sftp.company.com).
Network Security: Uses VPCs, subnets, and security groups to route traffic securely.

Data Storage with Amazon S3

Dedicated Bucket: Stores all transferred files in a secure S3 bucket (company-sftp-bucket-01).
Server-Side Encryption (SSE-S3): Encrypts data at rest.
Versioning: Maintains a change history for recovery purposes.
Cross-Account Access: Implements bucket policies to control external access.

Monitoring and Logging

CloudWatch Logging: Tracks authentication, file transfers, and system activity.
Metrics Tracking: Monitors login attempts, errors, and successes.
Alerts and Notifications: Detects suspicious behavior and triggers alerts.

Security and Compliance Enhancements

End-to-End Data Encryption: Ensures encryption in transit and at rest.
Granular IAM Policies: Restricts S3 access to specific users.
IP Restrictions: Allows access only from approved IPs via Secrets Manager.

Scalability and Efficiency

Amazon S3 Scalability: Seamlessly handles growing data volumes.
High Availability: Maintains uptime even with high user activity.
Automation: Reduces overhead by automating access, validation, and monitoring.

Conclusion

The AWS Transfer Family SFTP solution for the therapeutics company is a robust, secure, and scalable system designed to facilitate file transfers over SFTP while leveraging AWS managed services. The architecture ensures secure authentication, reliable storage, and efficient user management. By integrating services like AWS Secrets Manager, API Gateway, and Lambda, the solution provides a seamless and secure way to manage user access and file transfers. The solution uses Amazon S3 as the backend storage, providing a reliable and scalable place to store transferred files. Additionally, it supports both password-based and SSH key-based authentication, offering flexibility for different user needs. The system is designed with detailed logging and monitoring through CloudWatch, allowing for easy tracking of file transfers and user activity.

Overall, the solution is well-suited for organizations like this therapeutics company that require secure and scalable file transfer capabilities, with the added benefit of AWS's managed services reducing the operational overhead.

Discover how we can simplify secure file transfers in your AWS environment

Let our AWS experts show you how to implement scalable, compliant SFTP solutions with zero hassle.

Schedule a call

Get Secure, Scalable IT Built for Life Sciences

Whether you're launching a new lab, managing clinical research, or scaling biotech operations, PTP helps you move faster with compliant, cloud-first solutions.

Schedule your free consultation today.

The post Secure & Scalable AWS Transfer Family SFTP Solution for a Therapeutics Company appeared first on PTP | Cloud Experts | Biotech Enablers.

How PTP Helped Device42 Cut Downtime by 93% with AWS Lambda Automation

Mai Hiraoka — Fri, 04 Apr 2025 20:40:07 +0000

How PTP Helped Device42 Cut Downtime by 93% with AWS Lambda Automation

Device42, a global tech company trusted in over 70 countries, faced growing inefficiencies from a manual image-building pipeline that slowed releases and risked downtime. PTP stepped in to design an automated deployment framework using AWS Lambda, Amazon Machine Images (AMIs), and CloudWatch. The result? A highly scalable, self-healing system that slashed deployment downtime by 93% and recovered 7–10 hours of engineering time monthly—empowering Device42 to scale faster and innovate with confidence.

Reduction in downtime

Hours of engineering time saved per month

Used by Organizations

Challenges

Solutions

Conclusion

The Challenge

Device42, a technology company trusted by organizations in over 70 countries, met a critical bottleneck in its operational efficiency. Its Image Builder pipeline relied heavily on manual processes for creating, testing, and deploying system images. This labor-intensive approach introduced multiple pain points:

Excessive engineering time spent on repetitive manual tasks
Increased risk of human error and inconsistent configurations
Prolonged and unpredictable deployment cycles
Frequent downtime during updates (30–60 minutes per deployment)
Delayed feature releases and lack of scalability
Hindered ability to meet growing global demand

To maintain its competitive edge and ensure seamless service, Device42 needed to transform this fragile, time-consuming workflow into a resilient, automated pipeline capable of accelerating deployments, minimizing downtime, and delivering consistent, repeatable results across hybrid cloud environments.

The Solution

PTP designed a scalable automation framework to revolutionize the Image Builder pipeline. Key elements included:

AWS Lambda functions as the core orchestration layer

Triggered manually for scheduled releases or automatically via CloudWatch alarms during infrastructure issues

Automated pipeline that:

Pulled the latest Amazon Machine Images (AMIs)
Generated assets
Deployed them across environments

Auto Scaling Groups to manage server capacity dynamically

Load Balancers to optimize traffic distribution

Eliminated downtime and manual scaling efforts

The Outcome

Through PTP’s automation expertise, Device42 now operates a fully automated, cloud-native deployment framework, delivering measurable business benefits:

      7–10 hours saved per month in engineering effort
~93% reduction in deployment downtime (from 30–60 minutes down to just 2–4 minutes)
Increased release velocity through automation
Improved operational resilience and system reliability
Consistent infrastructure management across hybrid environments
Scalable DevOps foundation to support future innovation

    

Ready to Eliminate Downtime and Accelerate Deployments?

Partner with PTP to automate your infrastructure and unlock faster, more reliable delivery across hybrid cloud environments. Contact us today to get started.

Schedule a call

Scale Smarter, Not Harder

Let PTP help you modernize your infrastructure and reduce downtime. Schedule a free consultation today!

The post How PTP Helped Device42 Cut Downtime by 93% with AWS Lambda Automation appeared first on PTP | Cloud Experts | Biotech Enablers.

The Value of Using AWS Direct Connect in Biotech: Fast, Reliable, and Secure Cloud Connectivity

Mai Hiraoka — Thu, 07 Nov 2024 23:31:20 +0000

PTP Solves: How AWS Direct Connect Powers Fast, Secure Cloud Data for Biotech

Many biotech companies are moving operations to the cloud to access the magnitude of compute power needed to analyze the volume of data being generated with new technologies. However, achieving seamless, secure, and reliable connectivity between on-premises data centers and cloud infrastructure becomes critical. This is where AWS Direct Connect steps in, offering a high-performance, dedicated network connection to Amazon Web Services (AWS). In this blog, we’ll explore the key benefits of using AWS Direct Connect and why PTP may, or may not, recommend it to biotech companies seeking to manage their data from the lab to and in the cloud more effectively.

What is AWS Direct Connect?

AWS Direct Connect is a dedicated network connection between your on-premises environment and AWS. Unlike using the public internet or a virtual private network (VPN) to access AWS services, Direct Connect establishes a private, high-bandwidth connection, bypassing the potential bottlenecks and variability that can come with internet-based communication. It enables businesses to create a hybrid environment that links their local infrastructure to the global scale of AWS, enabling access to scalable cloud services.

Key Benefits of AWS Direct Connect

Enhanced Performance and Low Latency

One of the biggest advantages of AWS Direct Connect is its ability to provide a more consistent and lower-latency experience compared to internet-based connections. When dealing with time-sensitive applications, data transfers from lab devices, or workloads that require real-time processing, as low latency is critical. Direct Connect provides a high-performance link that ensures smooth and fast data transfers.

Improved Reliability

Public internet connections, including VPNs, are prone to network congestion, packet loss, and variability in speed. In contrast, AWS Direct Connect offers a more reliable and predictable connection by providing a dedicated, private link to AWS. This minimizes the risk of performance degradation caused by fluctuating internet traffic, providing biotech organizations the stability needed for data transfer and management.

Increased Bandwidth for High Data Transfers

Since biotech organizations can move large amounts of data between their on-premises data centers and AWS, the bandwidth offered by Direct Connect can significantly improve the efficiency and speed of these transfers. Whether you’re migrating databases, conducting backups, or running analytics on large data sets, Direct Connect can handle high-volume data movements more efficiently than a standard internet connection.

Cost Savings on Data Transfer

Using AWS Direct Connect can lead to cost savings on data transfer fees. AWS Direct Connect offers lower data transfer rates compared to using public internet access points. For biotech companies moving large amounts of data, these reduced data transfer costs can quickly add up to substantial savings over time.

Enhanced Security

Security is always a top concern when transferring sensitive data between environments. By providing a dedicated connection that bypasses the public internet, AWS Direct Connect significantly enhances data security. Businesses can leverage this private connection to reduce the exposure of their data to external threats, as well as use encrypted traffic between their on-premises environment and AWS for an additional layer of security.

Flexibility and Scalability

AWS Direct Connect supports multiple virtual interfaces, allowing businesses to connect to multiple VPCs, AWS accounts, or AWS regions from the same physical connection. This flexibility makes it easier for businesses to scale their operations and expand into new scalable cloud AWS services and regions without needing to establish additional connections.

Use Cases for AWS Direct Connect

Data-Intensive Workloads: For companies running big data analytics, machine learning models, or media processing, Direct Connect offers the high bandwidth and low latency required for efficient data transfers.

Real-Time Applications: If your company’s workflows require real-time processing, AWS Direct Connect provides a seamless, low latency integration between data collection, storage, and analysis. While internet connections may sometimes provide similar speeds, AWS Direct Connect can assure consistent performance, regardless of internet traffic inside or outside your organization.

Regulatory Compliance: By using Direct Connect’s private, dedicated network, biotech companies can streamline applicable compliance controls related to data transfer.

**Situations that PTP would NOT Recommend Direct Connect**

Very Early Stage: If your company is still in the early stages and has not reached the threshold for volume of data transfer that makes AWS Direct Connect more cost effective, we may recommend that you continue using a standard public internet connection. However, as part of our assessment process, we will make sure your environment is set up to be ready to seamlessly transition to AWS Direct Connect once the volume of data warrants it.

Conclusion

AWS Direct Connect provides growing, data-intensive biotech companies with a fast, reliable, and secure way to connect their on-premises environments to AWS. Whether you’re dealing with large-scale data transfers, running mission-critical applications, or operating in a hybrid cloud environment, Direct Connect offers enhanced performance, cost savings, and improved cloud data security. As cloud adoption continues to rise, AWS Direct Connect continues to be an essential service for companies looking to achieve high-performance cloud connectivity and ensure smooth, secure operations.

By leveraging AWS Direct Connect, biotech companies can unlock new levels of performance and scalability, enabling them to fully realize the potential of their scientific data.

Have you implemented AWS Direct Connect in your infrastructure? Share your experience or let the team at PTP know how you’re planning to take advantage of its benefits!

Need faster, more reliable cloud data transfers?
Unlock secure, high-performance cloud connectivity. Contact PTP to explore AWS Direct Connect solutions for biotech.

👉 Schedule a consultation todayor find us on 👉 AWS Marketplace

The post The Value of Using AWS Direct Connect in Biotech: Fast, Reliable, and Secure Cloud Connectivity appeared first on PTP | Cloud Experts | Biotech Enablers.

Voices of Innovation: Client Testimonials Illuminate PTP’s Impact at Bio-IT World 2024

Mai Hiraoka — Sun, 12 May 2024 00:32:53 +0000

Overview: PTP is highly regarded for its expertise and ability to facilitate operations in the cloud, especially within the biopharma and life sciences sectors. Their proficiency in AWS, cloud infrastructure, and networking—combined with their problem-solving capabilities—have made them an essential IT provider for life sciences companies aiming to accelerate drug discovery and scientific advancements.

Describing PTP in One Word: Insights from the Bio-IT World Conference 2024

At the recent Bio-IT World Conference, several industry professionals shared their experiences and perspectives on working with PTP. When asked to describe PTP in one word, the responses highlighted the company’s strengths and the value they bring to their clients.

Phenomenal
One participant summed up PTP in a single word: phenomenal—capturing the extraordinary level of service and support PTP provides to help clients reach their goals efficiently.

Competent
Reflecting deep technical expertise, “competent” was a word used to emphasize how PTP effectively manages IT infrastructure for biotech startups and life sciences operations.

Professional, Excellent, Passionate
These words echoed throughout testimonials. Clients consistently noted the professionalism of the team and their passion for enabling success in complex, regulated environments.

Partner & Ownership
Many described PTP as a true partner that takes full ownership of challenges, integrates seamlessly into client teams, and brings reliability and trust to every collaboration.

“They become part of your team… it’s like they’re in the office next to you.”

Zero to Science
This phrase was coined by a client who described how PTP’s team got their organization up and running in the cloud so quickly they could focus on research immediately. It’s a perfect expression of PTP’s value: taking care of the technical lift so life sciences companies can focus on discovery.

Expertise in AWS and Network Engineering
PTP’s deep experience in both network space and AWS was consistently praised, especially their ability to handle infrastructure challenges so clients can concentrate on science.

Flexible & Helpful
Clients emphasized PTP’s adaptability and willingness to solve problems—even when it meant thinking outside the box. This flexibility is key for companies navigating rapid change or scaling quickly in the biotech space.

Making a Difference
More than anything, clients appreciated working with a company that understands its role in accelerating healthcare innovation. PTP is helping clients scale in the cloud, enabling breakthroughs that lead to healthier, better lives.

Partnering to Advance Life Sciences Innovation
Through PeakPlus™ and its managed services, PTP enables fast, secure, and compliant infrastructure for life sciences companies, helping them focus on solving the world’s most pressing scientific problems.

View the full video on YouTube here

Customer Testimonials:

“Well, I think part of what they [PTP] bring is a tremendous amount of knowledge and a really strong relationship with AWS. We’re at the early stages, but they seem to have a really tremendous amount of experience in what those cloud deployments might look like, about some of the ways cloud can be employed to solve complicated or compute-expensive problems. And frankly, that’s not an area of expertise of ours, so it’s been really good for us to be able to partner with someone like that who has a lot of that knowledge about those nuances about how you would deploy something like AWS to address those customer needs.”

Daniel Weaver

Founder & CEO, Boulder BioConsulting

“They bring a skill set that I can’t find anywhere else. They’ve been really great partners, both in the network space, the AWS space, and sort of problem-solving for whatever I need. They’re willing to work outside of the box to figure out how they can help me in my business.”

Darren Tong

Head of IT, Orna Therapeutics

“When we were starting up a new fund, fund one is always a bit of a challenge because you have limited resources, you’re trying to hire the best and the brightest, and security is one of the most important items that you need to be able to tackle when you’re on a build. And being able to do that on budget with the right resources, PTP brought that to the table and was able to help us be ready for raising our fund one and building companies with vision.”

Bill Amsbaugh

CTO & Partner, Cure Ventures

“We have many challenges right now with the AWS footprint and we looking forward to PTP to help alleviate some of the issues that we are running into, and especially with the professionalism that PTP has displayed up this point I’m really excited to get going on this journey.”

Sathish Koduru

Head of Data Engineering, Neumora

“When we moved from one single account as a small company and we started growing and moved to a multi-account, PTP really helped us, informed us on the decision, how to do it properly, and helped us through the process of moving to a multi-account using the best practices.”

Yohann Potier

Sr. Director of Informatics, Tessera Therapeutics

About PTP
PTP is a leading IT provider for life sciences companies, delivering secure, scalable, and compliant technology solutions for biotech, clinical research, and healthcare organizations. As an AWS Advanced Tier Consulting Partner with the Life Sciences Competency, PTP specializes in managed IT services for life sciences, including cloud migration, FinOps, DevOps, cybersecurity, and cloud management.

Through its PeakPlus™ platform, PTP provides tailored MSP solutions for genomics, data science, and regulated research environments—supporting everything from HIPAA and GxP compliance to IT infrastructure for biotech startups and clinical trials. Based in Boston, PTP helps the world’s most innovative life sciences companies reduce costs, meet compliance goals, and accelerate discovery.

For more information, visit https://ptp.cloud.

Media Contact:

Gary Derheim
VP, Marketing & Business Development
marketing@ptp.cloud

Ready to Take the Next Step in Your Cloud Journey?

Whether you’re optimizing AWS costs, strengthening cybersecurity, or building scalable infrastructure for life sciences innovation, PTP is here to help. Our experts deliver tailored cloud, security, and FinOps solutions for fast-growing organizations. Contact us today to speak with our experts or explore our AWS Marketplace solutions.

Our Events Case Studies

The post Voices of Innovation: Client Testimonials Illuminate PTP’s Impact at Bio-IT World 2024 appeared first on PTP | Cloud Experts | Biotech Enablers.

Developing AI and ML Practices: Insights from Aaron Jeskey at Bio-IT World 2024

Mai Hiraoka — Fri, 10 May 2024 02:48:19 +0000

At the recent Bio-IT World 2024 conference in Boston, Aaron Jeskey, Sr. Cloud Architect of PTP provided valuable insights into the development of AI and ML practices within organizations. This discussion focused particularly on the challenges and strategies pertinent to sectors such as healthcare and life sciences.

The Journey of AI and ML Implementation

Aaron began by reflecting on PTP’s six-year journey since its pivotal experience at ReInvent 2018, where the unveiling of AWS’s DeepRacer platform significantly shaped their approach. DeepRacer, a model racecar that teaches reinforcement learning without a traditional remote control, demonstrated the practical impact and educational potential of AI within a business setting.

The Rational AI Architect Framework

Central to PTP’s methodology is the Rational AI Architect, a strategy rooted in applying the FAIR data principles—Findable, Accessible, Interoperable, and Reusable data—in a practical and sustainable manner. Aaron underscored the importance of a grounding statement to anchor any project’s objectives and reduce uncertainty. He cited an age-old adage to emphasize his point: “He who hurries more than he needs to, hurts before he needs to.” This quote encapsulates the philosophy of measured, thoughtful progress in AI and ML endeavors.

Applying FAIR Data Principles

Aaron discussed how each aspect of FAIR data could be effectively integrated from the start of a project:

Findable: The initial focus is on enhancing data lineage. Understanding not just what the data represents but also its origins and context is crucial for its effective use in scientific research and business applications.
Accessible: Maintaining data in its most atomic form is essential for accessibility. This approach ensures that even as data undergoes transformations or migrations, its core attributes remain intact and traceable.
Interoperable: Ensuring data’s usability across different platforms and by various users within the organization maximizes its value and fosters a collaborative environment.
Reusable: The goal is to keep data perennially relevant. As methodologies evolve or new team members join, reusable data stands as a robust foundation that can continuously support ongoing projects and innovations.

The Importance of Data Lineage and Atomic Data

Aaron elaborated on the practical aspects of data management, highlighting the importance of understanding who provides the data and the quality they can deliver. This understanding helps in making informed decisions about data usage. Keeping data atomic allows organizations to revisit and reutilize their information without the need for costly reprocessing, thus ensuring efficient and scalable operations.

Conclusion: Embracing a Structured Approach to AI and ML

Aaron’s talk at Bio World 2024 illuminated the path forward for organizations looking to integrate AI and ML into their operations effectively. By adopting the Rational AI Architect framework and adhering to the FAIR data principles from the outset, companies can ensure their AI and ML practices are both sustainable and adaptable to future changes and challenges.

For those interested in further exploring these strategies, PTP offers a funded Well-Architect Review that provides deeper insights into applying the Rational AI Architect approach in various environments, ensuring that organizations can embark on their AI and ML initiatives with confidence and clarity.

About PTP

Headquartered in Boston, PTP (Pinnacle Technology Partners, Inc.) delivers specialized cloud consulting, cybersecurity services, FinOps optimization, and managed IT solutions designed to meet the complex needs of life sciences, biotech, and healthcare organizations. As an AWS Advanced Tier Services Partner with Life Sciences Competency, PTP provides end-to-end solutions including AWS cloud migration, Well-Architected Reviews, managed security services, and cloud cost optimization strategies. Through its PeakPlus™ managed services platform and deep domain expertise, PTP empowers innovators to accelerate discovery, maintain regulatory compliance, and drive operational efficiency — all while protecting critical data assets.

For more information, visit https://ptp.cloud.

Media Contact:

Gary Derheim
VP, Marketing & Business Development
marketing@ptp.cloud

Ready to Take the Next Step in Your Cloud Journey?

Our Events Case Studies

The post Developing AI and ML Practices: Insights from Aaron Jeskey at Bio-IT World 2024 appeared first on PTP | Cloud Experts | Biotech Enablers.

Defining the Rational AI Architect for Life Sciences

Gary Derheim — Wed, 24 Apr 2024 11:57:36 +0000

Introduction

Join us in this intriguing webinar highlight as we delve into the emerging role of the Rational AI Architect. Discover the essence of this innovative position from an industry expert, as they explain the rational approach to AI architecture, contrasted against the conventional hype cycles in tech. Learn about the practical challenges and strategic thinking required to scale ambitions in smaller, less resourced teams, and how these pioneers navigate the complexities of modern software development in life sciences. Whether you’re an AI professional or just AI-curious, this video provides valuable insights into how minimal viable products and agile methodologies can be leveraged effectively to achieve ambitious technological goals. Don’t miss out on understanding how rational AI architects are shaping the future of technology in the life sciences sector!

Speakers
John Conway – Chief Visioneer Officer, 20/15 Visioneers
Aaron Jeskey – Sr. Cloud Architect, PTP

More about PTP’s CloudOps for Life Sciences!

In the ever-evolving field of Artificial Intelligence (AI), buzzwords and hype often cloud the true essence of what it takes to build robust AI systems. Amidst this, a new concept is emerging\u2014the Rational AI Architect. But what exactly does this term mean, and why is it gaining traction? Let’s explore the definition of a Rational AI Architect and what they bring to the table in AI development.<\/p>\n

Defining the Rational AI Architect<\/h2>\n
A Rational AI Architect is someone who takes a pragmatic approach to AI development, focusing on first principles and avoiding the hype cycle. This concept arises from years of experience in building technology solutions, often with a history of working in both large corporations and smaller startups. The rational approach involves breaking away from grandiose promises and focusing on what can be achieved realistically within the given constraints.<\/p>\n

The Genesis of the Rational AI Architect<\/h3>\n
The term “Rational AI Architect” might sound new, but it’s rooted in the basic principles of software development and engineering. It emerged from the need to address the disconnect between large, established companies with vast resources and smaller, agile startups trying to achieve similar goals. In a large corporation, AI projects often have the backing of extensive IT support and infrastructure. In contrast, a startup might have a team of 15 people with ambitious goals but limited resources.<\/p>\n
<\/a><\/p>\n

The Rational Approach<\/h3>\n
The rational approach is about asking, “What can we do today that makes a meaningful impact?” It involves focusing on Minimum Viable Products (MVPs) and building from the ground up, rather than aiming for massive, unrealistic milestones. This approach aligns with the concept of iteration\u2014making incremental progress through small, manageable steps.<\/p>\n
Challenges of the Rational Approach<\/h3>\n
The Rational AI Architect’s challenge lies in managing expectations and convincing stakeholders to embrace a more measured approach. In an industry filled with overachievers and individuals with multiple PhDs, asking, “What’s the least we can do to move the needle?” might seem counterintuitive. However, the rational approach emphasizes consistent, reliable progress over time.<\/p>\n
Implementing Rationality in AI Development<\/h2>\n
To implement the rational approach, AI architects must balance innovation with practicality. This means adopting iterative development processes, such as Agile or Kanban, to deliver regular updates and improvements. The goal is to avoid large-scale failures by constantly refining and adapting the project based on real-world feedback.<\/p>","tablet":"
In the ever-evolving field of Artificial Intelligence (AI), buzzwords and hype often cloud the true essence of what it takes to build robust AI systems. Amidst this, a new concept is emerging\u2014the Rational AI Architect. But what exactly does this term mean, and why is it gaining traction? Let's explore the definition of a Rational AI Architect and what they bring to the table in AI development.<\/p>\n
Defining the Rational AI Architect<\/h2>\n
A Rational AI Architect is someone who takes a pragmatic approach to AI development, focusing on first principles and avoiding the hype cycle. This concept arises from years of experience in building technology solutions, often with a history of working in both large corporations and smaller startups. The rational approach involves breaking away from grandiose promises and focusing on what can be achieved realistically within the given constraints.<\/p>\n
The Genesis of the Rational AI Architect<\/h3>\n
The term \"Rational AI Architect\" might sound new, but it's rooted in the basic principles of software development and engineering. It emerged from the need to address the disconnect between large, established companies with vast resources and smaller, agile startups trying to achieve similar goals. In a large corporation, AI projects often have the backing of extensive IT support and infrastructure. In contrast, a startup might have a team of 15 people with ambitious goals but limited resources.<\/p>\n
<\/a><\/p>\n
The Rational Approach<\/h3>\n
The rational approach is about asking, \"What can we do today that makes a meaningful impact?\" It involves focusing on Minimum Viable Products (MVPs) and building from the ground up, rather than aiming for massive, unrealistic milestones. This approach aligns with the concept of iteration\u2014making incremental progress through small, manageable steps.<\/p>\n
Challenges of the Rational Approach<\/h3>\n
The Rational AI Architect's challenge lies in managing expectations and convincing stakeholders to embrace a more measured approach. In an industry filled with overachievers and individuals with multiple PhDs, asking, \"What's the least we can do to move the needle?\" might seem counterintuitive. However, the rational approach emphasizes consistent, reliable progress over time.<\/p>\n
Implementing Rationality in AI Development<\/h2>\n
To implement the rational approach, AI architects must balance innovation with practicality. This means adopting iterative development processes, such as Agile or Kanban, to deliver regular updates and improvements. The goal is to avoid large-scale failures by constantly refining and adapting the project based on real-world feedback.<\/p>"}},"slug":"et_pb_text"}" data-et-multi-view-load-tablet-hidden="true">
In the ever-evolving field of Artificial Intelligence (AI), buzzwords and hype often cloud the true essence of what it takes to build robust AI systems. Amidst this, a new concept is emerging—the Rational AI Architect. But what exactly does this term mean, and why is it gaining traction? Let’s explore the definition of a Rational AI Architect and what they bring to the table in AI development.

Defining the Rational AI Architect

A Rational AI Architect is someone who takes a pragmatic approach to AI development, focusing on first principles and avoiding the hype cycle. This concept arises from years of experience in building technology solutions, often with a history of working in both large corporations and smaller startups. The rational approach involves breaking away from grandiose promises and focusing on what can be achieved realistically within the given constraints.

The Genesis of the Rational AI Architect

The term “Rational AI Architect” might sound new, but it’s rooted in the basic principles of software development and engineering. It emerged from the need to address the disconnect between large, established companies with vast resources and smaller, agile startups trying to achieve similar goals. In a large corporation, AI projects often have the backing of extensive IT support and infrastructure. In contrast, a startup might have a team of 15 people with ambitious goals but limited resources.

The Rational Approach

The rational approach is about asking, “What can we do today that makes a meaningful impact?” It involves focusing on Minimum Viable Products (MVPs) and building from the ground up, rather than aiming for massive, unrealistic milestones. This approach aligns with the concept of iteration—making incremental progress through small, manageable steps.

Challenges of the Rational Approach

The Rational AI Architect’s challenge lies in managing expectations and convincing stakeholders to embrace a more measured approach. In an industry filled with overachievers and individuals with multiple PhDs, asking, “What’s the least we can do to move the needle?” might seem counterintuitive. However, the rational approach emphasizes consistent, reliable progress over time.

Implementing Rationality in AI Development

To implement the rational approach, AI architects must balance innovation with practicality. This means adopting iterative development processes, such as Agile or Kanban, to deliver regular updates and improvements. The goal is to avoid large-scale failures by constantly refining and adapting the project based on real-world feedback.

The Importance of Avoiding Hype

A key aspect of the Rational AI Architect’s role is to avoid getting caught up in the hype cycle. This involves resisting the urge to pursue flashy solutions that may not align with the organization’s capabilities or long-term goals. Instead, the focus is on building sustainable, scalable AI systems that deliver tangible results.

Conclusion

The Rational AI Architect represents a new breed of AI professionals who prioritize practicality and long-term success over hype and unrealistic expectations. By breaking down complex problems into manageable components and focusing on first principles, these architects can guide organizations toward building AI solutions that stand the test of time. In a world where technology often seems easy, the Rational AI Architect reminds us that real progress comes from thoughtful, consistent effort.

Download the latest white paper on Scientific Data Management: Best Practices to Achieve R&D Operational Excellence

The post Defining the Rational AI Architect for Life Sciences appeared first on PTP | Cloud Experts | Biotech Enablers.